 CAMBRIDGE, Mass. and AUSTIN, Texas, June 8, 2021 PRNewswire -- Foundation Medicine, Inc. and Natera, Inc. NASDAQ: NTRA, today announced the launch of the research use version of FoundationOneTracker, Foundation Medicines personalized circulating tumor DNA ctDNA monitoring assay. 